요약정보
Evaluation of the 2021 ESC recommendations for family screening in hereditary transthyretin cardiac amyloidosis.
- Resource Type
- Academic Journal
- Authors
- Muller SA; Department of Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands.; Netherlands Heart Institute, Utrecht, The Netherlands.; Member of the European Reference Network for rare, low prevalence and complex diseases of the heart (ERN GUARD-Heart).; Peiró-Aventin B; Member of the European Reference Network for rare, low prevalence and complex diseases of the heart (ERN GUARD-Heart).; Department of Cardiology, Hospital Universitario Puerta de Hierro Majadahonda, IDIPHISA, CIBERCV, Madrid, Spain.; Biagioni G; Tuscan Regional Amyloid Centre, Careggi University Hospital, Florence, Italy.; Tini G; Cardiology, Department of Clinical and Molecular Medicine, Sapienza University of Rome, Rome, Italy.; Saturi G; Member of the European Reference Network for rare, low prevalence and complex diseases of the heart (ERN GUARD-Heart).; Cardiology Unit, Cardiac Thoracic and Vascular Department, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.; Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy.; Kronberger C; Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria.; Achten A; Department of Cardiology, Maastricht University, Cardiovascular Research Institute Maastricht (CARIM), Maastricht, The Netherlands.; Dobner S; Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.; 3rd Medical Department of Cardiology and Intensive Care Medicine, Clinic Ottakring (former Wilhelminenhospital), Vienna, Austria.; Te Rijdt WP; Member of the European Reference Network for rare, low prevalence and complex diseases of the heart (ERN GUARD-Heart).; Department of Genetics, Erasmus MC, Cardiovascular Institute, Thoraxcenter, Rotterdam, The Netherlands.; Gasperetti A; Division of Medicine, Department of Cardiology, Johns Hopkins University, Baltimore, MD, USA.; Te Riele ASJM; Department of Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands.; Member of the European Reference Network for rare, low prevalence and complex diseases of the heart (ERN GUARD-Heart).; Varrà GG; Member of the European Reference Network for rare, low prevalence and complex diseases of the heart (ERN GUARD-Heart).; Center for Diagnosis and Treatment of Cardiomyopathies, Cardiothorarcovascular Department, Azienda Sanitaria Universitaria Giuliano-Isontina, University of Trieste, Trieste, Italy.; Ponziani A; Member of the European Reference Network for rare, low prevalence and complex diseases of the heart (ERN GUARD-Heart).; Cardiology Unit, Cardiac Thoracic and Vascular Department, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.; Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy.; Hirsch A; Department of Cardiology, Erasmus MC, Cardiovascular Institute, Thoraxcenter, Rotterdam, The Netherlands.; Department of Radiology and Nuclear Medicine, Erasmus MC, Rotterdam, The Netherlands.; Porcari A; Member of the European Reference Network for rare, low prevalence and complex diseases of the heart (ERN GUARD-Heart).; Center for Diagnosis and Treatment of Cardiomyopathies, Cardiothorarcovascular Department, Azienda Sanitaria Universitaria Giuliano-Isontina, University of Trieste, Trieste, Italy.; van der Meer MG; Department of Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands.; Member of the European Reference Network for rare, low prevalence and complex diseases of the heart (ERN GUARD-Heart).; Zampieri M; Tuscan Regional Amyloid Centre, Careggi University Hospital, Florence, Italy.; van der Harst P; Department of Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands.; Member of the European Reference Network for rare, low prevalence and complex diseases of the heart (ERN GUARD-Heart).; Kammerlander A; Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria.; Biagini E; Member of the European Reference Network for rare, low prevalence and complex diseases of the heart (ERN GUARD-Heart).; Cardiology Unit, Cardiac Thoracic and Vascular Department, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.; van Tintelen JP; Netherlands Heart Institute, Utrecht, The Netherlands.; Member of the European Reference Network for rare, low prevalence and complex diseases of the heart (ERN GUARD-Heart).; Department of Genetics, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.; Barbato E; Cardiology, Department of Clinical and Molecular Medicine, Sapienza University of Rome, Rome, Italy.; Asselbergs FW; Member of the European Reference Network for rare, low prevalence and complex diseases of the heart (ERN GUARD-Heart).; Institute of Cardiovascular Science, Faculty of Population Health Sciences, University College London, London, UK.; Amsterdam University Medical Centers, Department of Cardiology, University of Amsterdam, Amsterdam, The Netherlands.; Health Data Research UK and Institute of Health Informatics, University College London, London, UK.; Menale S; Tuscan Regional Amyloid Centre, Careggi University Hospital, Florence, Italy.; Gräni C; Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.; Merlo M; Member of the European Reference Network for rare, low prevalence and complex diseases of the heart (ERN GUARD-Heart).; Center for Diagnosis and Treatment of Cardiomyopathies, Cardiothorarcovascular Department, Azienda Sanitaria Universitaria Giuliano-Isontina, University of Trieste, Trieste, Italy.; Michels M; Member of the European Reference Network for rare, low prevalence and complex diseases of the heart (ERN GUARD-Heart).; Department of Cardiology, Erasmus MC, Cardiovascular Institute, Thoraxcenter, Rotterdam, The Netherlands.; Knackstedt C; Member of the European Reference Network for rare, low prevalence and complex diseases of the heart (ERN GUARD-Heart).; Department of Cardiology, Maastricht University, Cardiovascular Research Institute Maastricht (CARIM), Maastricht, The Netherlands.; Nitsche C; Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria.; Longhi S; Member of the European Reference Network for rare, low prevalence and complex diseases of the heart (ERN GUARD-Heart).; Cardiology Unit, Cardiac Thoracic and Vascular Department, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.; Musumeci B; Cardiology, Department of Clinical and Molecular Medicine, Sapienza University of Rome, Rome, Italy.; Cappelli F; Tuscan Regional Amyloid Centre, Careggi University Hospital, Florence, Italy.; Garcia-Pavia P; Member of the European Reference Network for rare, low prevalence and complex diseases of the heart (ERN GUARD-Heart).; Department of Cardiology, Hospital Universitario Puerta de Hierro Majadahonda, IDIPHISA, CIBERCV, Madrid, Spain.; Universidad Francisco de Vitoria, Pozuelo de Alarcón, Spain.; Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.; Oerlemans MIFJ; Department of Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands.; Member of the European Reference Network for rare, low prevalence and complex diseases of the heart (ERN GUARD-Heart).
- Source
- Publisher:
Wiley Country of Publication: England NLM ID: 100887595 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0844 (Electronic) Linking ISSN:13889842 NLM ISO Abbreviation: Eur J Heart Fail Subsets: MEDLINE - Subject
- Language
- English